AstraZeneca and University of Oxford's Coronavirus Vaccine Approved in India
The world's second most populous country has approved two coronavirus vaccines, one of which is AZD1222 developed by AstraZeneca (NASDAQ: AZN) in collaboration with the University of Oxford. On Sunday, the Central Drugs Standard Control Organization (CDSCO) granted emergency use approval to AZD1222 (known as Covishield in India) and Covaxin, a vaccine developed by Indian company Bharat Biotech.
This is the second major regulatory authorization for AZD1222 in the space of a week. Last Wednesday, the U.K. healthcare regulator granted it similar approval for emergency use.
Image source: Getty Images.
Source Fool.com
